Industrial, Manufacturing & Heavy Industry Market News

Research report explores the p2x purinoceptor 3 pipeline (p2rx3) review

Research report explores the p2x purinoceptor 3 pipeline (p2rx3) review

The P2X Purinoceptor 3 (P2RX3) Pipeline Review, H2 2017 report summarizes all the dormant and discontinued pipeline projects.

- Agency -.

P2X Purinoceptor 3 (P2RX3)Pipeline outlays comprehensive information on the P2X Purinoceptor 3 (P2RX3) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in P2X Purinoceptor 3 (P2RX3) targeted therapeutics development with respective active and dormant or discontinued projects.

Report: www.reportsnreports.com/contacts/.aspx?name=1132600

P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein that in humans is encoded by the P2RX3 gene. It belongs to the family of purinoceptors for ATP.

- Agency -.

This receptor functions as a ligand-gated ion channel and may transduce ATP-evoked nociceptor activation. This receptor is important for peripheral pain responses, and also participates in pathways controlling urinary bladder volume reflexes.
Companies are Asana BioSciences LLC, Bayer AG, BELLUS Health Inc, Integral Molecular Inc, Merck & Co Inc, Neurim Pharmaceuticals Ltd, Pfizer Inc.

P2X Purinoceptor 3 pipeline (P2RX3) Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies.

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 2, 3 and 3 respectively. Report covers products from therapy areas Central Nervous System, Cardiovascular, Respiratory, Genito Urinary System And Sex Hormones, Ophthalmology and Women's Health which include indications Neuropathic Pain, Chronic Cough, Chronic Pain, Hypertension, Visceral Pain, Abdominal Pain, Alzheimer's Disease, Endometriosis, Idiopathic Pulmonary Fibrosis, Inflammatory Pain, Insomnia, Interstitial Cystitis (Painful Bladder Syndrome), Memory Impairment, Migraine, Ocular Hypertension, Open-Angle Glaucoma, Osteoarthritis Pain, Pain, Resistant Hypertension and Respiratory Tract Infections.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Access Complete Report On P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2017: www.reportsnreports.com/.aspx?name=1132600

Scope
- The report provides a snapshot of the global therapeutic landscape for P2X Purinoceptor 3 (P2RX3)
- The report reviews P2X Purinoceptor 3 (P2RX3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in P2X Purinoceptor 3 (P2RX3) targeted therapeutics and enlists all their major and minor projects
- The report assesses P2X Purinoceptor 3 (P2RX3) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to P2X Purinoceptor 3 (P2RX3) targeted therapeutics

 

List of Figures
Number of Products under Development for Hypertension, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017

 

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.